{
  "created_at": "2021-06-11T16:46:51.035Z",
  "title": "Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval",
  "url": "https://www.reuters.com/world/us/third-member-us-fda-advisory-panel-resigns-over-alzheimers-drug-approval-2021-06-10/",
  "author": "mrfusion",
  "points": 156,
  "story_text": null,
  "comment_text": null,
  "num_comments": 121,
  "story_id": null,
  "story_title": null,
  "story_url": null,
  "parent_id": null,
  "created_at_i": 1623412682,
  "_tags": [
    "story",
    "author_mrfusion",
    "story_27472107",
    "front_page"
  ],
  "objectID": "27472107",
  "_highlightResult": {
    "title": {
      "value": "Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval",
      "matchLevel": "none",
      "matchedWords": []
    },
    "url": {
      "value": "https://www.reuters.com/world/us/third-member-us-fda-advisory-panel-resigns-over-alzheimers-drug-approval-2021-06-10/",
      "matchLevel": "none",
      "matchedWords": []
    },
    "author": {
      "value": "mrfusion",
      "matchLevel": "none",
      "matchedWords": []
    }
  },
  "original_created_at": "2021-06-11T11:58:02.000Z",
  "image": "https://www.reuters.com/resizer/uu9vHWBFQI0AxVM8XVKU8jd-j1I=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/7V2MAHYVNJIB3K475NQWJMWKZM.jpg"
}